These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 9927304)

  • 1. Inhibitory and stimulatory effects of somatostatin on two human pancreatic cancer cell lines: a primary role for tyrosine phosphatase SHP-1.
    Douziech N; Calvo E; Coulombe Z; Muradia G; Bastien J; Aubin RA; Lajas A; Morisset J
    Endocrinology; 1999 Feb; 140(2):765-77. PubMed ID: 9927304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatostatin inhibits Akt phosphorylation and cell cycle entry, but not p42/p44 mitogen-activated protein (MAP) kinase activation in normal and tumoral pancreatic acinar cells.
    Charland S; Boucher MJ; Houde M; Rivard N
    Endocrinology; 2001 Jan; 142(1):121-8. PubMed ID: 11145574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatostatin activation of mitogen-activated protein kinase via somatostatin receptor 1 (SSTR1).
    Florio T; Yao H; Carey KD; Dillon TJ; Stork PJ
    Mol Endocrinol; 1999 Jan; 13(1):24-37. PubMed ID: 9892010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct inhibitory effects of a somatostatin analog, SMS 201-995, on AR4-2J cell proliferation via pertussis toxin-sensitive guanosine triphosphate-binding protein-independent mechanism.
    Viguerie N; Tahiri-Jouti N; Ayral AM; Cambillau C; Scemama JL; Bastié MJ; Knuhtsen S; Estève JP; Pradayrol L; Susini C
    Endocrinology; 1989 Feb; 124(2):1017-25. PubMed ID: 2563240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autocrine regulation of human prostate carcinoma cell proliferation by somatostatin through the modulation of the SH2 domain containing protein tyrosine phosphatase (SHP)-1.
    Zapata PD; Ropero RM; Valencia AM; Buscail L; López JI; Martín-Orozco RM; Prieto JC; Angulo J; Susini C; López-Ruiz P; Colás B
    J Clin Endocrinol Metab; 2002 Feb; 87(2):915-26. PubMed ID: 11836342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulation of tyrosine phosphatase and inhibition of cell proliferation by somatostatin analogues: mediation by human somatostatin receptor subtypes SSTR1 and SSTR2.
    Buscail L; Delesque N; Estève JP; Saint-Laurent N; Prats H; Clerc P; Robberecht P; Bell GI; Liebow C; Schally AV
    Proc Natl Acad Sci U S A; 1994 Mar; 91(6):2315-9. PubMed ID: 7907795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatostatin receptor 1 (SSTR1)-mediated inhibition of cell proliferation correlates with the activation of the MAP kinase cascade: role of the phosphotyrosine phosphatase SHP-2.
    Florio T; Thellung S; Arena S; Corsaro A; Bajetto A; Schettini G; Stork PJ
    J Physiol Paris; 2000; 94(3-4):239-50. PubMed ID: 11088001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of growth and metastatic progression of pancreatic carcinoma in hamster after somatostatin receptor subtype 2 (sst2) gene expression and administration of cytotoxic somatostatin analog AN-238.
    Benali N; Cordelier P; Calise D; Pages P; Rochaix P; Nagy A; Esteve JP; Pour PM; Schally AV; Vaysse N; Susini C; Buscail L
    Proc Natl Acad Sci U S A; 2000 Aug; 97(16):9180-5. PubMed ID: 10900262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The activation of the phosphotyrosine phosphatase eta (r-PTP eta) is responsible for the somatostatin inhibition of PC Cl3 thyroid cell proliferation.
    Florio T; Arena S; Thellung S; Iuliano R; Corsaro A; Massa A; Pattarozzi A; Bajetto A; Trapasso F; Fusco A; Schettini G
    Mol Endocrinol; 2001 Oct; 15(10):1838-52. PubMed ID: 11579215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. sst2 Somatostatin receptor inhibits cell proliferation through Ras-, Rap1-, and B-Raf-dependent ERK2 activation.
    Lahlou H; Saint-Laurent N; Estève JP; Eychène A; Pradayrol L; Pyronnet S; Susini C
    J Biol Chem; 2003 Oct; 278(41):39356-71. PubMed ID: 12878607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuronal nitric oxide synthase: a substrate for SHP-1 involved in sst2 somatostatin receptor growth inhibitory signaling.
    Lopez F; Ferjoux G; Cordelier P; Saint-Laurent N; Estève JP; Vaysse N; Buscail L; Susini C
    FASEB J; 2001 Oct; 15(12):2300-2. PubMed ID: 11511520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation in vitro of somatostatin receptor subtypes 2, 3, or 4 stimulates protein tyrosine phosphatase activity in membranes from transfected Ras-transformed NIH 3T3 cells: coexpression with catalytically inactive SHP-2 blocks responsiveness.
    Reardon DB; Dent P; Wood SL; Kong T; Sturgill TW
    Mol Endocrinol; 1997 Jul; 11(8):1062-9. PubMed ID: 9212054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatostatin analogues inhibit growth of pancreatic cancer by stimulating tyrosine phosphatase.
    Liebow C; Reilly C; Serrano M; Schally AV
    Proc Natl Acad Sci U S A; 1989 Mar; 86(6):2003-7. PubMed ID: 2564678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth effects of regulatory peptides and intracellular signaling routes in human pancreatic cancer cell lines.
    Douziech N; Lajas A; Coulombe Z; Calvo E; Lainé J; Morisset J
    Endocrine; 1998 Oct; 9(2):171-83. PubMed ID: 9867251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nerve growth factor exerts differential effects on the growth of human pancreatic cancer cells.
    Zhu ZW; Friess H; Wang L; Bogardus T; Korc M; Kleeff J; Büchler MW
    Clin Cancer Res; 2001 Jan; 7(1):105-12. PubMed ID: 11205897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory role of the somatostatin receptor SST2 on the intracrine-regulated cell proliferation induced by the 210-amino acid fibroblast growth factor-2 isoform: implication of JAK2.
    Hortala M; Ferjoux G; Estival A; Bertrand C; Schulz S; Pradayrol L; Susini C; Clemente F
    J Biol Chem; 2003 Jun; 278(23):20574-81. PubMed ID: 12665520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The tyrosine phosphatase SHP-1 associates with the sst2 somatostatin receptor and is an essential component of sst2-mediated inhibitory growth signaling.
    Lopez F; Estève JP; Buscail L; Delesque N; Saint-Laurent N; Théveniau M; Nahmias C; Vaysse N; Susini C
    J Biol Chem; 1997 Sep; 272(39):24448-54. PubMed ID: 9305905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of pancreatic tyrosine kinase and phosphatase activities by cholecystokinin and somatostatin.
    Rivard N; Lebel D; Lainé J; Morisset J
    Am J Physiol; 1994 Jun; 266(6 Pt 1):G1130-8. PubMed ID: 7912895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Octapeptide somatostatin analog SMS 201-995 induces translocation of intracellular PTP1C to membranes in MCF-7 human breast adenocarcinoma cells.
    Srikant CB; Shen SH
    Endocrinology; 1996 Aug; 137(8):3461-8. PubMed ID: 8754775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Critical role of Src and SHP-2 in sst2 somatostatin receptor-mediated activation of SHP-1 and inhibition of cell proliferation.
    Ferjoux G; Lopez F; Esteve JP; Ferrand A; Vivier E; Vely F; Saint-Laurent N; Pradayrol L; Buscail L; Susini C
    Mol Biol Cell; 2003 Sep; 14(9):3911-28. PubMed ID: 12972574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.